Manufacturing scale-up is a major focus in order to meet projected commercial demands and reduce costs for supply.
We have developed manufacturing processes employing two dimensional (2D) technology, and have made significant advances in the development of three dimensional (3D) bioreactor technology. Our manufacturing activities have met stringent criteria set by international regulatory agencies.
The manufacturing and distribution process for our off-the-shelf mesenchymal lineage cell product candidates generally involves five major steps:
